Cargando…
Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and the prognosis of MM patients remains poor. Objective: To identify and validate a genetic prognostic signature in patients with MM. Methods: Co-expression network was constructed to identify hub genes r...
Autores principales: | Liu, Xiao-Ping, Yin, Xiao-Hong, Meng, Xiang-Yu, Yan, Xin-Hui, Wang, Fan, He, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331463/ https://www.ncbi.nlm.nih.gov/pubmed/30671382 http://dx.doi.org/10.3389/fonc.2018.00615 |
Ejemplares similares
-
Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022) -
Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma
por: Wang, Jing, et al.
Publicado: (2023) -
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
por: Su, Rongjia, et al.
Publicado: (2022) -
Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020) -
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
por: Jia, Shuangshuang, et al.
Publicado: (2022)